A
$ Value
$0
Shares
6,209
Price
$0
Filed
Dec 3
Insider
Name
Gallagher Duncan
Title
—
CIK
0001780880
Roles
Director
Transaction Details
Transaction Date
2025-12-01
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
124,461
Footnotes
Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on December 1, 2025.
Filing Info
Gallagher Duncan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | HCAT | A | $0 |
| 2025-12-01 | HCAT | A | $0 |
| 2025-09-01 | HCAT | A | $0 |
| 2025-07-09 | HCAT | A | $0 |
| 2025-06-01 | HCAT | A | $0 |
Other Insiders at HCAT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Llewelyn Linda
Chief People Officer
|
— | — | 2026-03-02 |
| Gallagher Duncan | — | — | 2026-02-17 |
| Larson-Green Julie | — | — | 2026-03-01 |
|
Alger Jason
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Landry Benjamin
General Counsel
|
— | — | 2026-03-02 |
|
Albert Benjamin
CEO
|
— | — | 2026-03-10 |